Provided by Tiger Fintech (Singapore) Pte. Ltd.

Applied Therapeutics Inc.

0.3326
-0.0004-0.12%
Volume:1.87M
Turnover:601.42K
Market Cap:47.09M
PE:-0.44
High:0.3484
Open:0.3450
Low:0.3051
Close:0.3330
Loading ...

Applied Therapeutics CEO Shendelman Steps Down

Dow Jones
·
20 Dec 2024

BRIEF-Applied Therapeutics Appoints John H. Johnson As Executive Chairman

Reuters
·
20 Dec 2024

Applied Therapeutics Appoints John H. Johnson as Executive Chairman

THOMSON REUTERS
·
20 Dec 2024

Applied Therapeutics Inc - Les Funtleyder Appointed Interim CEO

THOMSON REUTERS
·
20 Dec 2024

Applied Therapeutics Inc - Funtleyder to Continue as CFO While Serving as Interim CEO

THOMSON REUTERS
·
20 Dec 2024

Applied Therapeutics Inc - Shoshana Shendelman Steps Down as CEO

THOMSON REUTERS
·
20 Dec 2024

Class Action Filed Against Applied Therapeutics, Inc. (APLT) Seeking Recovery for Investors – Contact Levi & Korsinsky LLP

TIPRANKS
·
18 Dec 2024

Applied Therapeutics Inc - Joel Marcus Resigns From Applied Therapeutics Board

THOMSON REUTERS
·
11 Dec 2024

Will Applied Therapeutics (NASDAQ:APLT) Spend Its Cash Wisely?

Simply Wall St.
·
03 Dec 2024

Stock Track | Applied Therapeutics Plunges 5.14% Pre-market After FDA Warning Letter on Genetic Disease Drug Trial

Stock Track
·
03 Dec 2024

Stock Track | Applied Therapeutics Inc. Plummets 5.42% After UBS Downgrades to Neutral, Slashes Price Target

Stock Track
·
03 Dec 2024

Applied Therapeutics says it received FDA's warning letter for genetic disease drug study

Reuters
·
03 Dec 2024

Applied Therapeutics: Following Issuance of a Complete Response Letter by FDA, Received Warning Letter Limited to at-007-1002 Study

THOMSON REUTERS
·
03 Dec 2024

Applied Therapeutics Faces Uncertainty After US FDA Rejects NDA for Govorestat in Galactosemia, UBS Says

MT Newswires Live
·
03 Dec 2024

Company News for Dec 2, 2024

Zacks
·
02 Dec 2024

UBS Downgrades Applied Therapeutics to Neutral From Buy, Cuts Price Target to $2 From $13

MT Newswires Live
·
02 Dec 2024

Applied Therapeutics Inc : UBS Cuts to Neutral From Buy

THOMSON REUTERS
·
02 Dec 2024

Applied Therapeutics Inc : UBS Cuts Target Price to $2 From $13

THOMSON REUTERS
·
02 Dec 2024

Applied Therapeutics Inc : Citigroup Cuts Target Price to $8 From $13

THOMSON REUTERS
·
02 Dec 2024

Post-Bell | S&P 500, Dow Close at Record Highs; Nvidia Gains 2%; Tesla Jumps 4%; Super Micro Sinks 7%

Tiger Newspress
·
30 Nov 2024